Skip to Content


Notice of Prospective Patent License

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


National Aeronautics and Space Administration.


Notice of Prospective Patent License.


NASA hereby gives notice that Critical Care Innovations, Inc., having offices in Chantilly, Virginia, has applied for a partially exclusive license to practice the invention described and claimed in U.S. Patent No. 5,869,238, entitled “Quantitative Method of Measuring Metastatic Activity,” and in continuations, divisional applications, and foreign applications corresponding to this case. The 5,869,238 patent is assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. Written objections to the prospective grant of a license should be sent to the Johnson Space Center.


Responses to this notice must be received by March 19, 2003.

Start Further Info


James Cate, Patent Attorney, NASA Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone (281) 483-1001.

Start Signature

Dated: February 26, 2003.

Robert M. Stephens,

Deputy General Counsel.

End Signature End Further Info End Preamble

[FR Doc. 03-5042 Filed 3-3-03; 8:45 am]